PARP1 and Stroke: The first studies to recognize this issue have been conducted in murine models of stroke, where PARP inhibition or PARP1 deficiency produced marked benefit in male animals, but, paradoxically, in female animals, the protection was absent, and, in fact, in some cases, exacerbation of the injury was noted [47,70,71,72,73].